Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Madrigal Pharmaceuticals Inc (NASDAQ:MDGL)

12.56
Delayed Data
As of 1:13pm ET
 +0.29 / +2.36%
Today’s Change
5.25
Today|||52-Week Range
72.80
+1.95%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization738.0K516.0K673.0K662.0K
 
 
 
 
 
 
Operating ExpensesGross Income---516.0K-673.0K-662.0K
 
 
 
 
General Expenses60.4M87.0M83.3M66.9M
 
 
 
 
 
Research And Development49.4M71.9M68.2M54.2M
 
 
 
 
 
Total Operating Expenses61.1M87.6M84.0M67.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-61.1M-87.6M-84.0M-67.6M
 
 
 
 
 
Interest Expense On Debt1.8M2.6M2.2M1.1M
 
 
 
 
 
Other Expenses147.0K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-62.8M-90.2M-86.2M-68.7M
 
 
 
 
 
Net Income-62.8M-90.2M-86.2M-68.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.7M2.0M2.8M3.7M
 
 
 
 
 
Shares To Calculate EPS Diluted1.7M2.0M2.8M3.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$37.10-$44.45-$30.45-$18.55
 
 
 
 
 
EPS Diluted-$37.10-$44.45-$30.45-$18.55